The PRESS RA: Protein and Resistance Exercise Supplementation Study for Rheumatoid Arthritis
NCT ID: NCT02078375
Last Updated: 2019-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
23 participants
INTERVENTIONAL
2014-02-28
2018-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistance Exercise in Rheumatic Disease
NCT01599260
The Effects of a 16-Week Individualized, Intensive Strength Training Program in Patients With Rheumatoid Arthritis
NCT00327275
Progressive Resistance Exercise in Rheumatoid Arthritis
NCT02219022
Muscle Wasting and Rheumatoid Arthritis Flares
NCT06400316
Efficacy of Resistance Exercise and an Anti-Inflammatory Diet on Pain, Disease Activity, Functional Status, and Quality of Life in Patients With Rheumatoid Arthritis
NCT07262112
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Carbohydrate supplement
Participants will be enrolled in a twice weekly resistance exercise program. They will receive a carbohydrate supplement to take twice daily (once after exercise).
Carbohydrate (Placebo)
The twice daily placebo will consist of a carbohydrate and a small amount of protein
Resistance Exercise Program
All participants will be enrolled in an individually supervised twice weekly (for 16 weeks) resistance exercise program
Protein Supplementation
Participants will be enrolled in a twice weekly resistance exercise program. They will receive a twice daily protein supplement (once after exercise).
Protein
whey protein plus casein protein
Resistance Exercise Program
All participants will be enrolled in an individually supervised twice weekly (for 16 weeks) resistance exercise program
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Protein
whey protein plus casein protein
Carbohydrate (Placebo)
The twice daily placebo will consist of a carbohydrate and a small amount of protein
Resistance Exercise Program
All participants will be enrolled in an individually supervised twice weekly (for 16 weeks) resistance exercise program
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* diagnosis of rheumatoid arthritis
* willing to participate in twice weekly exercise sessions
Exclusion Criteria
* recent heart surgery (within past 12 months)
* severe kidney disease
* use of supplemental oxygen
* presence of pacemaker
* diabetes that requires insulin for management
* allergy to soy or milk
60 Years
95 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute on Aging (NIA)
NIH
American College of Rheumatology Research and Education Foundation
OTHER
Johns Hopkins University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rebecca L. Manno, MD, MHS
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Johns Hopkins Bayview Campus
Baltimore, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NA_00088317
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.